期刊文献+

血液灌流对尿毒症透析患者IL-6、IL-8、TNF-α的影响 被引量:5

Effect of hemoperfusion on the serum levels of IL-6,IL-8 and TNF-α in hemodialysis patients with uremia
下载PDF
导出
摘要 目的:探讨血液灌流(HP)串联血液透析(HD)对透析患者血清IL-6、IL-8、TNF-α的影响。方法:选30例维持性HD患者,采用自身对照法,行HD串联HP治疗设为(HD+HP)组,行常规血透设为HD组。分别测定两组治疗前后的IL-6、IL-8、TNF-α水平。结果:(1)(HD+HP)组治疗后TNF-a显著下降(P<0.05),IL-6、IL-8稍有下降,但无统计学意义(P>0.05)。(2)HD组治疗后TNF-α、IL-6、IL-8均略微上升,但差异无显著性。结论:常规血透治疗后患者血清IL-6、IL-8、TNF-α无下降,HP串联HD治疗后IL-6、IL-8略微下降,血清TNF-α明显下降,有利于改善尿毒症患者的细胞免疫功能。 Objective:To investigate the effect and clinical significance of hemoperfusion (HP) on the serum levels of IL-6,IL-8 and TNF-α in hemodialysis CHD) patients with uremia.Methods:With the self-controlled method,30 maintenance hemodialysis patients enrolled in this study were divided into two groups,which were treated with the combined treatment of hemodialysis and hemoperfusion as HD plus HP group and with hemodialysis alone as HD group.The serum levels of IL-6,IL-8 and TNF-α were detected respectively before and after the treatment.Results:(1)After the treatment, the serum level of TNF-α in the HD plus HP group was decreased significantly (P〈0.05);the serum levels of IL-6 and IL-8 decredsed slightly without statistically significant differenct (P〈0.05).(2)AII the serum levels of TNF-α,IL-6 and IL-8 were increased slightiy,but without significant difference.Condusion:Hemodialysis has no effects on the serum levels of IL-6,IL-8 and TNF-α.The combined treatment hemodialysis and hemoperfusion can safely and effectively clear the serum level of TNF-αso it is benefical to correct the abnormal immune status in the uremic patients.
出处 《现代医药卫生》 2007年第3期328-329,共2页 Journal of Modern Medicine & Health
关键词 血液灌流 血液透析 肿瘤坏死因子-Α 白介素-6 白介素-8 Hemaperfusion Hemodialysis Tumor necrosis factor-α,Intedeukin-6 Interleukin-8
  • 相关文献

参考文献6

二级参考文献20

  • 1Takayama F,Miyazaki S,Morita T,et al.Dialysis-related amyloidosis of the heart in long-term hemodialysis patients[J].Kidney Int Suppl,2001,78:S172-176.
  • 2Mikhalovsky SV,Emerging technologies in extracorporeal treatment:focus on adsorption[J].Perfusion,2003,18(7):47-45.
  • 3James F,et al.Removal of Middle Molecules with Sorbents[J].Artif Cells Blood Substit Immobil Biotechnol,2002,30(5-6):547-554.
  • 4Winchester JF,et al:The next step from high-flux dialysis:application of sorbent technology[J].Blood Purif,2002,20(1):81-86.
  • 5Gejyo F,Kawaguchi Y,Hara S,et al.Arresting dialysis-related amyloidosis:a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column[J].Artif Organs,2004 ,28(4):371-380.
  • 6Clark WR,et al.Middle molecules and small-molecular-weight protiens in ESRD:Properties and strategies for their removal[J].Adv Ren Replace Ther,2003,10(4):270-278.
  • 7Ronco C,Brendolan A,Winchester JF,Et al.First clinic experience with an adjunctive hemoperfusion devices design specifically to remove beta 2-microglobulins in hemodialysis[J].Contrib Nephrol,2001,133:166-173.
  • 8Morena MD,Guo D,Balakirishna VS,et al.Effect of a novel adsorbent on cytoking responsiveness to uremic plasma[J].Kidney Int,2003,63(3):1150-1154.
  • 9Lornoy W,Becaus I,Billiouw JM,et al.On-line haemodiafiltration.Remarkable removal of beta2-microglobulin.Long-term clinical observations[J].Nephrol Dial Transplant,2000,15 Suppl 1:49-54 .
  • 10[3]Luster MI, Germolec DR, Yoshida T, et al. Endotoxin induced cytokine gene expression and excretion in the liver. Hepatology, 1994,19:480

共引文献39

同被引文献62

引证文献5

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部